Privately held biopharmaceutical company developing NavacimsTM to treat autoimmune diseases.
Parvus Therapeutics Inc. is a privately held biopharmaceutical company developing NavacimsTM to treat autoimmune diseases. The company is seeking an Associate Scientist to help drive projects enabling the preclinical PK/PD characterization of pMHC NP towards clinical and combination therapy evaluation.
Privately held biopharmaceutical company developing NavacimsTM to treat autoimmune diseases.
Lifelancer